Drugs / ARMS-I
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03026205 | Jan 2017 | viral respiratory tract infection | University of Toledo Health Science Campus | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARMS-I | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03026205 ↗ |
| Route | Oral | “administered orally” NCT03026205 ↗ |